Physician profile
Mandy Flor
NPI 1376998484
$2,428.91
in general payments reported to CMS, 2019-2025
11 companies · $942 in 2025
The $942 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,487 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694 · Long Term Medical Supply Or Device Loan: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.82 |
| Long Term Medical Supply Or Device Loan | $735.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,370.12 | 2024-2025 | Integra, Micromatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $327.73 | 2024-2025 | |
| Polynovo North America LLC | $240.74 | 2024 | Novosorb Btm |
| Kerecis Limited | $167.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Avita Medical Americas, LLC | $110.85 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Solventum Corporation | $73.94 | 2024 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Musculoskeletal Transplant Foundation INC. | $39.08 | 2024 | |
| Mentor Worldwide LLC | $31.92 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Depuy Synthes Sales INC. | $29.30 | 2024 | Na, Trumatch |
| Tela Bio, INC. | $20.72 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $17.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Flor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.